Lb Pharmaceuticals

Developer of small molecule based therapeutics for schizophrenia

placeNew York City, New York, United States calendar_todayFounded 2015 language lbpharma.us

1 investor on record.

Investor type	Count	Share
Venture capital	1	100%

Coming soon